Daicel Corporation (TYO:4202)

Market Cap	324.79B
Revenue (ttm)	586.53B
Net Income (ttm)	49.48B
Shares Out	265.13M
EPS (ttm)	181.44
PE Ratio	6.75
Forward PE	5.67
Dividend	60.00 (4.88%)
Ex-Dividend Date	Mar 28, 2025

Volume	544,500
Average Volume	699,310
Open	1,209.00
Previous Close	1,225.00
Day's Range	1,191.00 - 1,213.50
52-Week Range	1,059.00 - 1,639.50
Beta	0.20
RSI	45.65
Earnings Date	May 13, 2025

About Daicel

Daicel Corporation engages in the materials, medical/healthcare, smart, safety, engineering plastics, and other businesses in Japan, China, and internationally. The company offers acetic acid, acetic acid derivative chemicals, acetate tow, acetic anhydride, thioglycolic acid, caprolactone derivatives, methyl 3-methoxyacrylate, cycloaliphatic epoxies, alkylamines comprising diethylhydroxyamine, and 1,3-butylene glycol, as well as cellulose acetate; and Actranza Lab, a drug delivery device. It also provides solutions for the electronics market, s...

• Industry: Specialty Chemicals
• Sector: Materials
• Founded: 1919
• Employees: 11,134
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 4202

Financial Performance

In 2024, Daicel's revenue was 586.53 billion, an increase of 5.10% compared to the previous year's 558.06 billion. Earnings were 49.48 billion, a decrease of -11.38%.